These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25778882)

  • 21. Gastrointestinal amyloidosis: an often unexpected finding with systemic implications.
    Hagen CE; Dasari S; Theis JD; Rech KL; Dao LN; Howard MT; Dispenzieri A; Chiu A; Dalland JC; Kurtin PJ; Gertz MA; Kourelis TV; Muchtar E; Vrana JA; McPhail ED
    Hum Pathol; 2023 Sep; 139():27-36. PubMed ID: 37390975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-specific extraction using organic solvents.
    Kamiie J; Aihara N; Uchida Y; Kobayashi D; Yoshida Y; Kuroda T; Sakaue M; Sugihara Y; Rezeli M; Marko-Varga G
    MethodsX; 2020; 7():100770. PubMed ID: 32140436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.
    Vrana JA; Gamez JD; Madden BJ; Theis JD; Bergen HR; Dogan A
    Blood; 2009 Dec; 114(24):4957-9. PubMed ID: 19797517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue.
    Barreca A; Bottasso E; Veneziano F; Giarin M; Nocifora A; Martinetti N; Attanasio A; Biancone L; Benevolo G; Roccatello D; Cassoni P; Papotti MG;
    PLoS One; 2021; 16(8):e0256306. PubMed ID: 34428239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.
    Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J
    Intern Med J; 2022 Jan; 52(1):69-78. PubMed ID: 32981138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
    Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
    Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples.
    Dasari S; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dispenzieri A; Gertz MA; Hasadsri L; Highsmith WE; Kurtin PJ; McPhail ED
    Mayo Clin Proc; 2020 Sep; 95(9):1852-1864. PubMed ID: 32861330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histopathological diagnosis of amyloidosis].
    Hoshii Y
    Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry.
    Gonzalez Suarez ML; Zhang P; Nasr SH; Sathick IJ; Kittanamongkolchai W; Kurtin PJ; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera Hernandez LP; Said SM; Sethi S; Dispenzieri A; Gertz MA; Leung N
    Kidney Int; 2019 Oct; 96(4):1005-1009. PubMed ID: 31447055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition.
    Li D; Liu D; Xu H; Yu XJ; Zhou FD; Zhao MH; Wang SX
    BMC Nephrol; 2019 Dec; 20(1):476. PubMed ID: 31870425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
    Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
    Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass spectrometry-based absolute quantification of amyloid proteins in pathology tissue specimens: Merits and limitations.
    Ogawa M; Shintani-Domoto Y; Nagashima Y; Ode KL; Sato A; Shimizu Y; Ohashi K; Roehrl MHA; Ushiku T; Ueda HR; Fukayama M
    PLoS One; 2020; 15(7):e0235143. PubMed ID: 32609750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits.
    Abildgaard N; Rojek AM; Møller HE; Palstrøm NB; Nyvold CG; Rasmussen LM; Hansen CT; Beck HC; Marcussen N
    Amyloid; 2020 Mar; 27(1):59-66. PubMed ID: 31752543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
    Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
    Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pilot Study of Rare Renal Amyloidosis Based on FFPE Proteomics.
    Meng S; Xia W; Xia L; Zhou L; Xu J; Pan X; Meng L
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.